Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-25-033683

CEO and President gave up 7,001 shares (to pay taxes)

  • CEO and President acquired 28,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KLEMP WALTER V CEO and President 2025-11-04 Option exercise +28,750 772,357 D
KLEMP WALTER V CEO and President 2025-11-04 Shares withheld for taxes −7,001 $0.50 $3,479 765,356 D
Derivatives
KLEMP WALTER V CEO and President 2025-11-04 Option exercise · Restricted Stock Units −28,750 2,380,731 D
Loading xslF345X05/rdgdoc.xml…